Testing effectiveness (Phase 2)Study completedNCT01516307
What this trial is testing
Trial of Active Immunotherapy With Globo H-KLH (OPT-822) in Metastatic Breast Cancer Subjects
Who this might be right for
Metastatic Breast Cancer
OBI Pharma, Inc 349